Classification of Septic Shock Phenotypes Based on the Presence of Hypotension and Hyperlactatemia in Cats

Introduction

Sepsis, the life-threatening organ dysfunction caused by a dysregulated host response to infection, is a global health burden affecting critically-ill people and veterinary patients (1–3). According to the Third International Consensus Definition Sepsis-3 septic shock is defined as a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone. Risk-adjusted in-hospital mortality is significantly higher in human patients with fluid-refractory hypotension (systolic blood pressure [SBP] <90 mmHg or mean blood pressure [MAP] <60 mmHg) and hyperlactatemia (blood lactate concentrations >2 mmol/L) compared with either hyperlactatemia alone or with fluid resistant hypotension requiring vasopressors but with normal blood lactate concentrations (1).

A reclassification of the spectrum of septic patients using lactate had been proposed in people recognizing three different phenotypes of shock: dysoxic, vasoplegic, and cryptic (4–6). Dysoxic shock, defined by the combination of hyperlactatemia and hypotension requiring vasopressor support, is characterized by higher illness severity scores, higher mean number of organ dysfunctions and lower survival rates (4–6). Vasoplegic shock is a more favorable phenotype where patients requiring prolonged vasopressor therapy for hypotension do not develop hyperlactatemia (7). Septic humans with vasoplegic shock usually present lower severity scores and lower rates of hospital mortality, suggesting a more preserved global homeostasis despite the evidence of circulatory stress (7–9). Finally, the presence of occult hypoperfusion characterized by persistent hyperlactatemia in absence of hypotension is defined as cryptic shock. Severity of illness and mortality in patients with cryptic shock could be equivalent to those in patients with vasoplegic shock. This suggests that sole standing hyperlactatemia increases risk of death independently from vasopressor need. Therefore, such patients might require the same level of intensive care as hypotensive patients (4–6, 10, 11). Stratification of septic patients based on these different septic shock phenotypes could be of fundamental epidemiological and prognostic importance. Moreover, hyperlactatemia may be considered a predictor of mortality, regardless of the phenotypes of septic shock (4–6, 9–11).

In small animals, septic shock is defined as a state of fluid-refractory hypotension requiring vasopressor support and is reportedly associated with higher mortality rates compared to uncomplicated sepsis (3, 12–15). However, feline septic shock is not commonly investigated (3, 15), and the stratification and the prognostic impact of the different septic shock phenotypes based on hyperlactatemia and fluid-refractory hypotension have not yet been documented.

The aims of the current study were: (1) to analyze the prevalence and characteristics of different phenotypes of septic shock, defined by the presence of fluid-refractory hypotension requiring vasopressor support and/or hyperlactatemia, in a population of cats with septic shock hospitalized in an intensive care unit (ICU); (2) to compare the clinical presentation and outcome of this population of cats with septic shock to a cohort of cats with uncomplicated sepsis. We hypothesized that cats with septic shock have greater illness severity and experience worse outcomes compared to cats with uncomplicated sepsis, and that the feline septic shock phenotypes resemble the ones identified in humans in terms of prevalence, risk for organ dysfunction and mortality.

Materials and Methods

Study Population and Setting

Cats with sepsis presented to a Veterinary University Hospital between April 2018 and November 2020 and hospitalized in the ICU for at least 12 h were eligible for inclusion. Cats were diagnosed with sepsis based on the presence of infection confirmed by means of cytology, microbiology, histopathology or real-time polymerase chain reaction, plus at least one of the following: fulfill two or more Systemic Inflammatory Response Syndrome (SIRS) criteria (2); a serum amyloid-A (SAA) concentration above the laboratory reference interval (RI) (>10 μg/mL); evidence of at least one new-onset organ dysfunction. Cats with sepsis were diagnosed with septic shock if they had persistent hyperlactatemia (lactate >4 mmol/L for >12 h despite fluid resuscitation or clinical euvolemia) and/or hypotension (MAP <60 mmHg) requiring vasopressor support despite adequate fluid resuscitation (1). Cats not fulfilling septic shock criteria were placed in the uncomplicated sepsis category for statistical analysis. Serial monitoring of blood lactate was regularly performed at the end of fluid resuscitation, and then at different time intervals at the clinician discretion. Cats diagnosed with neoplasia, as well as cats discharged against medical advice or euthanized for financial reasons were excluded. The study was approved by the local Institutional Animal Care and Use Committee (protocol number ID 846).

Data Collection

Signalment, body weight, body condition score (BCS; where 1–3/9 was defined as underweight condition, 4–6/9 as ideal and 7–9/9 as obese), medical history including comorbidities, previous and current treatments, physical examination including non-invasive systolic blood pressure measurement (SunTech^® Vet20^TM Veterinary Blood Pressure Monitor, SunTech Medical, Inc., USA) were recorded at study enrollment. Attending ICU clinicians were responsible for the clinical management of the patients. Blood was collected by venipuncture with vacuum system according to standard operating procedures. Blood gas, electrolytes, and blood lactate measurements were performed using point-of-care analyzers (ABL800 FLEX, Radiometer Medical ApS, Denmark). Complete blood count and serum chemistry analyses including SAA evaluation were performed using automated analyzers (ADVIA 2120, Siemens Healthcare Diagnostics, Tarrytown, NY; Olympus AU 480, Olympus/Beckman Coulter, Brea, CA). SAA concentrations were measured on serum samples using a commercial immunoturbidimetric assay designed for human SAA (LZ Test Eiken SAA, Eiken Chemical, Tokyo, Japan), as previously validated for cats and applied in our lab (16, 17). The 5-variables feline Acute Patient Physiologic and Laboratory Evaluation fast (APPLE_fast) score was calculated in cats with uncomplicated sepsis and septic shock (18). Multiorgan dysfunction syndrome (MODS) was defined as the presence of at least two dysfunctional organs simultaneously, as previously reported (3) and as depicted in Table 1. Outcome was defined as survival to hospital discharge, death or euthanasia due to grave prognosis.

TABLE 1

Table 1. Criteria for organ dysfunction in cats (3).

Additional Data Collection in Cats With Septic Shock

Additional data were systematically recorded in cats diagnosed with septic shock: the 10-variables APPLE full score (APPLE_full); intravenous fluid volumes administered during resuscitation and during the first 24 h of hospitalization; type and duration of vasopressor support.

Septic Shock Phenotypes

Cats with septic shock were divided into subgroups according to three different phenotypes, as previously reported in humans: (1) cryptic shock, defined as hyperlactatemia (>4 mmol/L) in the absence of vasopressor support; (2) vasoplegic shock, defined as hypotension (MAP <60 mmHg) requiring vasopressor support in the absence of hyperlactatemia; (3) dysoxic shock, defined by the combination of hypotension requiring vasopressor support and hyperlactatemia (4–6, 10).

Statistical Analysis

Normality of data distribution was assessed graphically and using the D'Agostino Pearson test. Data were reported as median and range (minimum-maximum value), or mean ± standard deviation (SD), based on their distribution. The Mann-Whitney U-test, Student's t-test and the Kruskal-Wallis test with post-hoc comparison were used to compare continuous variables among groups (uncomplicated sepsis vs. septic shock; cryptic vs. vasoplegic vs. dysoxic shock; cryptic shock vs. uncomplicated sepsis; survivors vs. non-survivors). Categorical variables were compared among groups using the Fisher's exact test and the Chi squared test. Associations between variables of interest and death for the overall population of septic cats were examined by univariate regression analysis, and the variables that were associated with the outcome (P < 0.05) were included in a multivariable regression model (stepwise selection); results were presented as odds ratio (OR) and 95% confidence interval (CI). For all tests applied, a value of P < 0.05 was considered significant. Statistical analysis was performed using a statistical software package (MedCalc Statistical Software version 19.1.3 Ostend, Belgium 2019).

Results

The study included 85 cats. From those 48/85 (56%) had uncomplicated sepsis and 37/85 (44%) had septic shock. Among the cats with uncomplicated sepsis, there were 12 spayed females, nine intact females, 19 neutered males and eight intact males. There were 39 domestic shorthair cats and nine purebred cats (three Siamese cats, two Persian cats, one Birman, one Ragdoll, one Bengal, one Main Coon). The median age was 4 years (0.16–17) and the mean body weight was 3.7 ± 1.6 kg. The BCS was between 1 and 3 in 24/48 (50%), between 4 and 6 in 21/48 (44%) cats, and 7 in 3/48 (6%) cats, respectively. Twenty-nine of 48 (60%) cats had at least two of four SIRS criteria. Underlying causes for sepsis included pyelonephritis (n = 15), trauma with infected wounds (n = 7), pyothorax (n = 6), feline panleukopenia virus infection (n = 6), septic peritonitis (n = 5), bacterial cholangitis (n = 4), pyometra (n = 4), abdominal abscess (n = 1).

Among the cats affected by septic shock, there were 12 spayed females, eight intact females, ten neutered males and seven intact males. There were 36 domestic shorthair cats and one Bengal. The median age was 6 years (0.16–16) and the mean body weight was 3.5 ± 1.8 kg. The BCS was between 1 and 3 in 20/37 (54%), between 4 and 6 in 13/37 (35%), and 7 in 4/37 (11%) cats, respectively. Twenty-eight of 37 (76%) cats met at least two of four SIRS criteria. Underlying causes for septic shock included trauma with infected wounds (n = 11), feline panleukopenia (n = 7), bacteremia in the course of heterogeneous diseases (2 acute gastroenteritis, 1 diabetic ketoacidosis, 1 ingestion of caustics; n = 5), pyelonephritis (n = 5), septic peritonitis (n = 4), bacterial cholangitis (n = 3), pyothorax (n = 2), abdominal abscesses (n = 1).

Comparison Among Septic Shock Phenotypes

At the time of inclusion 17/37 (46%) cats were affected by dysoxic shock, 11/37 (30%) had vasoplegic shock, while 7/37 (19%) had cryptic shock. Two cats with persistent hypotension requiring vasopressor support were excluded from phenotyping because no contextual blood lactate measurement was performed.

Clinical and clinicopathological characteristics of the three septic shock phenotypes are summarized in Table 2. Age, body weight and BCS were not different among groups. Cats with dysoxic shock had significantly higher median APPLE_fast and APPLE_full scores compared to cases from the other subgroups (Figure 1). The overall amount of intravenous fluids used for fluid resuscitation and during the first 24 h of hospitalization were not different in the three septic shock phenotypes. Length of hospital stay and mortality rates were not significantly different among cryptic, dysoxic and vasoplegic shock (Table 3, Figure 2). The frequency of MODS was significantly lower in cats with cryptic shock (57%, 4/7) compared to cases affected by dysoxic (94%, 16/17) and vasoplegic (100%, 11/11) shock (Figure 3).

TABLE 2

Table 2. Clinical and clinicopathological variables results in cats with sepsis and septic shock.

FIGURE 1

Figure 1. Box and whisker plots comparing the APPLE_fast and APPLE_full scores among cats with cryptic shock (n = 7, in blue), dysoxic shock (n = 17, in green), and vasoplegic shock (n = 11, in red). The central lines represent the median, the boundaries of the boxes represent the interquartile range and the whiskers represent the minimum and maximum values. Cats with dysoxic shock had significantly higher APPLE_fast and APPLE_full scores compared to cats with cryptic and vasoplegic shock (P < 0.001 and P < 0.015, respectively).

TABLE 3

Table 3. Clinical and clinicopathological variables in cats with dysoxic shock, cryptic shock, and vasoplegic shock.

FIGURE 2

Figure 2. Bar chart with 100% stacked columns showing mortality rate (in dark blue) in cats with cryptic shock (n = 7, 57%), dysoxic shock (n = 17, 65%), and vasoplegic shock (n = 11, 91%). The difference was not statistically significant (P = 0.09).

FIGURE 3

Figure 3. Bar chart with 100% stacked columns showing the percentage in MODS occurrence (in dark blue) in cats with cryptic shock (n = 7, 57%), dysoxic shock (n = 17, 94%) and vasoplegic shock (n = 11, 100%). The difference was statistically significant (P = 0.02). MODS, multiorgan dysfunction syndrome.

All cats with septic shock characterized by persistent fluid-refractory hypotension (dysoxic and vasoplegic shock) received norepinephrine as the first-line vasopressor. No difference in terms of norepinephrine hours of administration was reported between dysoxic and vasoplegic shock cases.

Three cats initially diagnosed with cryptic shock developed dysoxic shock within 24 h.

Comparison Between Cats With Septic Shock vs. Cats With Uncomplicated Sepsis

The comparison of selected clinical and clinicopathological variables between cases with uncomplicated sepsis and septic shock is summarized in Table 3. Cats with septic shock had a significantly higher frequency of MODS (91% vs. 28%, P < 0.0001) and a significantly higher mortality rate (73% vs. 43%, P = 0.0085) than cats with uncomplicated sepsis.

In the overall population of enrolled cats, patients presenting with at least 2/4 SIRS criteria had significantly higher frequency of MODS (76% vs. 24%, P = 0.022) and mortality (67% vs. 36%, P = 0.01) compared to those not fulfilling the feline SIRS criteria.

Comparison Between Cryptic Shock vs. Uncomplicated Sepsis

Additional comparisons were made between cryptic shock cases and cats with uncomplicated sepsis. No significant differences were identified for APPLE_fast score (27 vs. 27, P = 0.22), MODS occurrence (57% vs. 29%, P = 0.30) and mortality rate (57% vs. 43%, P = 0.68).

Comparison Between Survivors vs. Non-survivors

In the overall population of enrolled cats, 48/85 (56%) died, of whom 26/48 (54%) were euthanized. Selected clinical and clinicopathological variables in survivors and non-survivors are reported in Table 4. Non-survivors had significantly lower body temperature and BCS, as well as lower hematocrit, lymphocyte count and serum albumin compared to survivors. Moreover, circulating methemoglobin, serum bilirubin, serum urea, activated partial thromboplastin time and APPLE_fast score were higher in non-survivors. Non-survivors had greater occurrence of MODS compared to survivors (74% vs. 38%, P = 0.0033), and presented overall a shorter duration of hospital stay. Variables that were significantly different between survivors and non-survivors were entered into a univariate logistic regression analysis. There were positive associations between odds of mortality and body temperature, lymphocyte count, APPLE_fast score, low BCS (1–3) and MODS occurrence. MODS and lymphocyte count were the only variables retained in the multivariate model (OR = 4.3, CI 1.5–12.4; OR = 0.99, CI 0.99–1.0, respectively).

TABLE 4

Table 4. Clinical and clinicopathological variables in survivors and non-survivors in the study population.

Discussion

This prospective study includes a large population of cats with sepsis and septic shock, and explores the features of three septic shock phenotypes based on the presence of hypotension, hyperlactatemia, or both. In this regard, we hypothesized that the prognostic implications of the three septic shock phenotypes in cats resemble the ones reported in humans.

Demographic data, sepsis etiologies and mortality rates in our study population were comparable with the results of previous studies in septic cats (2, 3, 15, 17, 19, 20). Moreover, we were able to identify all three septic shock phenotypes with the dysoxic shock being the most represented. However, differences in terms of major outcomes emerged in contrast to human literature. Length of hospital stay was not different among the septic shock phenotypes. Mortality rates increased from cryptic (57%) to dysoxic (65%) and vasoplegic (91%) shock, but the difference was not significant. Moreover, no difference was detected in terms of vasopressor requirements (hours of administration) between dysoxic and vasoplegic shock phenotypes. Both dysoxic and vasoplegic shock were characterized by an overall greater illness severity, with higher numbers of patients with more frequent occurrence of MODS and higher APPLE scores. Hence, in feline sepsis, fluid-refractory hypotension seems to carry an elevated risk of morbidity and organ dysfunction regardless the presence of concurrent hyperlactatemia. Thus, even if a mortality difference was not apparent, the different morbidity of the three septic shock phenotypes could be equally relevant in the context of veterinary medicine, where the possibility of euthanasia confounds disease course and outcome in a notable way.

Unexpectedly, cats with cryptic shock were indeed comparable in terms of illness severity, outcome and MODS frequency to the ones affected by uncomplicated sepsis. In addition, lactate concentration upon hospital admission was similar between survivors and non-survivors. The prognostic utility of lactate concentrations in cats appears unclear according to the available literature. In the study by Shea et al. (21) investigating blood lactate in cats with arterial hypotension, normolactatemic patients had higher blood pressure and higher survival rates compared to hyperlactatemic patients. The authors hypothesized that normolactatemia in hypotensive patients could indicate an early state of disease with preserved organ perfusion. In a study including sick cats evaluated at an emergency service, patients with abnormal perfusion variables (pale mucous membranes, hypothermia, poor pulse quality) had higher lactate concentrations compared to cats without these findings, possibly indicating severe shock and altered tissue oxygen delivery (21). Nonetheless, neither initial or serial lactate measurements have shown prognostic significance in sick cats (22, 23). Despite the similar findings, comparison between these and our results is difficult considering the differences in patient cohorts and specifically their illness severity. It might be possible that blood lactate has a weaker prognostic value in septic cats compared to humans and dogs (24), but the impact of potential confounders (e.g., lack of standard sampling site, impact of restraint, type B hyperlactatemia, low number of cases per group) has to be considered.

Besides hypotension and hyperlactatemia, cats with septic shock had significantly lower body temperature compared with the ones affected by uncomplicated sepsis. Hypothermia is commonly included in the triad of feline shock, but its occurrence linked with severe sepsis and septic shock has been documented only in few of studies (15, 20). Hence, hypothermia even during triage should immediately prompt complete patient screening inclusive of blood pressure and lactate measurement in order to better assess perfusion. Cats with septic shock had higher APPLE_fast score, MODS occurrence and mortality rate compared to cats with uncomplicated sepsis. These results, overall, corroborate the concept of septic shock as the subset of sepsis characterized by substantially greater severity and worse prognosis.

The mortality rate in the overall study population was 56%. Non-survivors were generally characterized by more severe clinical and clinicopathological abnormalities, including lower body temperature and higher APPLE_fast score compared to survivors.

Interestingly, most of the cats in our population presented with a low-normal BCS, and being underweight was associated with an increased risk of death. It has been previously showed that a poor nutritional condition has a negative impact on wound repair, immune function, strength of skeletal and respiratory muscles, and might negatively affect outcome in hospitalized cats (25). Our results might support this statement, although a cause-effect relationship cannot be demonstrated. Among hematological variables, non-survivors had significantly lower lymphocyte count compared to survivors. Lymphocyte count was significantly associated with death in both univariate and multivariate analyses. Lymphopenia in cats usually accompany an inflammatory leukogram, but might also suggest a state of ineffective immune response. However, to the author's knowledge, it has not previously emerged as an outcome predictor in feline sepsis. Interestingly, apoptosis-induced lymphopenia is documented in septic people, and both its duration and depth have been linked with poor prognosis (26).

In the current study, MODS occurrence had a major impact on final outcome, being associated with a 5-fold increase in the risk of death in the multivariate regression analysis. Sepsis-associated mortality is highly related to the development of MODS in people (27). As a syndrome, MODS is intimately related to the individual host response to infection, and recognizes several mechanisms including disruption of microcirculation, endothelial damage, mitochondrial dysfunction and uncontrolled apoptosis (27). Previous studies have shown that MODS is a frequent complication in septic cats and similarly to this study has been associated with worse outcomes (3). Thus, our results strongly support frequent organ function assessment in septic cats, since early MODS detection can be crucial in preventing its progression.

Based on the criteria applied for the present study, 28/85 (33%) cats were considered septic despite showing <2/4 SIRS criteria. This result demands consideration, as sepsis could have been missed in about one third of the overall study population if only the traditional criteria proposed for cats were used (2). Despite the low sensitivity and specificity for sepsis diagnosis, the SIRS criteria might still have a place in identifying cats with higher disease severity. Indeed, according to our results, meeting the SIRS criteria was associated with worse outcomes and more frequent occurrence of MODS. On the contrary, SAA concentration was comparable between cats with uncomplicated sepsis and septic shock, as well as between survivors and non-survivors. Similar results had been previously reported, and indicate that despite SAA having a great value to recognize systemic inflammation in cats, its prognostic utility seems poor (15, 17).

There are some limitations to acknowledge when interpreting our results. The present study defined sepsis as the combination of infection plus either fulfillment of two or more SIRS criteria, increased SAA concentrations or evidence of new-onset organ dysfunction. These are novel criteria for sepsis in the veterinary literature. Our choice was based on multiple reasons. The SIRS criteria were insensitive to cats with confirmed infection and organ dysfunction in the study by Babyak and Sharp (2), and SAA has been demonstrated to be an excellent marker of systemic inflammation in cats (17). In human medicine, a data driven approach has been conducted to derive novel clinical criteria for sepsis redefinition and identification (1). An equivalent redefinition of sepsis in veterinary medicine has not been undertaken; however, in the Authors opinion, the assessment of acute phase proteins and markers of organ function to supplement SIRS criteria could be a strategy to apply to ameliorate sepsis identification. Similarly, the present study defined septic shock based on the presence of persistent hyperlactatemia or the need of vasopressors to support blood pressure. While hyperlactatemia has been recently incorporated into the human sepsis 3 definitions (1), no clear role for persistent hyperlactatemia has been defined in veterinary medicine. Another limitation of our study was intrinsically related to blood pressure measurement performed using a non-invasive indirect technique, which could be inaccurate especially in the hypotensive setting. Moreover, this was a single-center study; hence, our results might not be extrapolated in different settings. No sample size calculation was performed and, despite the reasonable size of the whole cohort of septic and septic shock cats, the number of cases per-group was small. According to the mortality rates detected in the present study a minimum number of 25 patients per group would have been necessary to detect a difference between vasoplegic and cryptic shock cases (type I error 0.05 and 80% power). This preliminary evidence limits the statistical power of our comparisons. Diagnostic and therapeutic interventions were left at the discretion of the attending clinician, thus no standardization in terms of blood sampling site was performed and peripheral and jugular lactate measurements were used interchangeably. Nonetheless, a pilot study did not report a significant difference between cephalic and jugular lactate in cats, even in the presence of hypotension (28). This shows that the sampling site might have limited impact on obtained lactate concentrations in cats. Cats were considered affected by cryptic shock only after the presence of sustained hyperlactatemia despite euvolemia and adequate fluid resuscitation, but the timing for lactate monitoring was not standardized, and no struggling score was calculated. However, the majority of cats with cryptic shock remained hyperlactatemic for a period of time ranging from 12 to 24 h, corroborating the possibility of an actual sustained hyperlactatemia refractory to fluid therapy. We did not attempt to differentiate between type A and type B hyperlactatemia. Specifically, among the factors and comorbidities potentially linked with type B hyperlactatemia there were steroid therapy (n = 3), diabetic ketoacidosis (n = 2) and hepatic lipidosis (n = 1). Those patients, and others with unknown predisposing factors, might have had hyperlactatemia without any metabolic, cellular or perfusion derangement. Interestingly hyperlactatemia B does not seem to be distinguished from hyperlactatemia A in studies in people with cryptic shock (4–6). According to our study design, the APPLE_fast and APPLE_full scores were calculated for cats in septic shock, while only the APPLE_fast score was evaluated in cats with uncomplicated sepsis for financial and case management reasons. This choice prevented a further comparison between these groups. In addition, the lack of external validation concerning the APPLE scores prevents us to get any strong conclusion regarding their clinical relevance in our population. Finally, despite exclusion of cats with financially-driven euthanasia, the number of cats euthanized for disease severity was high, limiting the value of the comparisons concerning length of hospital stay and outcome.

Conclusion

Septic shock in cats defines a subset of patients with greater disease severity, organ dysfunction and mortality compared to uncomplicated sepsis. At least three different septic shock phenotypes can be identified in feline sepsis. Despite similar in-hospital mortality, cats with dysoxic and vasoplegic shock are characterized by greater organ dysfunction compared to cats affected by cryptic shock. When compared to cats affected by uncomplicated sepsis, cryptic shock cases were not different in terms of illness severity and MODS occurrence. This new spectrum of feline septic shock phenotypes based on hypotension and hyperlactatemia warrants further research in larger study populations to implement epidemiological data and better delineate prognostic implications.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The project was approved by the Animal Welfare Committee (COBA) of the Alma Mater Studiorum – University of Bologna (Bologna ID 846).

Author Contributions

RT and MG designed the study, analyzed the data, co-wrote, and edited the manuscript. FB, EC, and AF analyzed the data, co-wrote, and edited the manuscript. IM, GM, and FD edited the manuscript. All authors contributed to read and approved the final manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

APPLE_fast, Acute Patient Physiologic and Laboratory Evaluation fast score; APPLE_full, Acute Patient Physiologic and Laboratory Evaluation full score; BCS, body condition score; CI, confidence interval; %FO, percentage of fluid overload; ICU, intensive care unit; OR, odds ratio; MAP, mean blood pressure; MODS, multiorgan dysfunction syndrome; SBP, systolic blood pressure; SIRS, Systemic Inflammatory Response Syndrome; SAA, serum amyloid A.

References

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801–10. doi: 10.1001/jama.2016.0287

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Babyak JM, Sharp CR. Epidemiology of systemic inflammatory response syndrome and sepsis in cats hospitalized in a veterinary teaching hospital. J Am Vet Med Assoc. (2016) 249:65–71. doi: 10.2460/javma.249.1.65

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Troia R, Mascalzoni G, Calipa S, Magagnoli I, Dondi F, Giunti M. Multiorgan dysfunction syndrome in feline sepsis: prevalence and prognostic implication. J Feline Med Surg. (2019) 21:559–65. doi: 10.1177/1098612X18792106

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Thomas-Rueddel DO, Poidinger B, Weiss M, Bach F, Dey K, Haberle H, et al. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock. J Crit Care. (2015) 30:439. doi: 10.1016/j.jcrc.2014.10.027

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Ranzani OT, Monteiro MB, Ferreira EM, Santos SR, Machado FR, Noritomi DT, et al. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock. Rev Bras Ter Insensiva. (2013) 24:270–8. doi: 10.5935/0103-507X.20130047

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Swenson KE, Dziura JD, Aydin A, Reynolds J, Wira CR. Evaluation of a novel 5-group classification system of sepsis by vasopressor use and initial serum lactate in the emergency department. Intern Emerg Med. (2018) 13:257–68. doi: 10.1007/s11739-017-1607-y

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Sterling SA, Puskarich MA, Shapiro NI, Trzeciak S, Kline JA, Summers RL, et al. Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock. Shock. (2013) 40:11–4. doi: 10.1097/SHK.0b013e318298836d

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Hernandez G, Castro R, Romero C, de la Hoz C, Angulo D, Aranguiz I. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock? J Crit Care. (2011) 26:435. doi: 10.1016/j.jcrc.2010.09.007

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Hernandez G, Bruhn A, Castro R, Pedreros C, Rovegno M, Kattan E, et al. Persistent sepsis-induced hypotension without hyperlactatemia: a distinct clinical and physiological profile within the spectrum of septic shock. Crit Care Res Pract. (2012) 2012:536852. doi: 10.1155/2012/536852

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Yang WS, Kang HD, Jung SK, Lee YJ, Oh SH, Kim YJ, et al. A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (Sepsis-3). Clin Respir J. (2020) 14:857–63. doi: 10.1111/crj.13218

PubMed Abstract | CrossRef Full Text | Google Scholar

11. April MD, Donaldson C, Tannenbaum LI, Moore T, Aguirre J, Pingree A, et al. Emergency department septic shock patient mortality with refractory hypotension vs hyperlactatemia: a retrospective cohort study. Am J Emerg Med. (2017) 35:1474–9. doi: 10.1016/j.ajem.2017.04.055

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Silverstein DC, Santoro Beer KA. Controversies regarding the choice of vasopressor therapy for management of septic shock in animals. J Vet Emerg Crit Care. (2015) 25:48–54. doi: 10.1111/vec.12282

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Dickinson AE, Summers JF, Wignal J, Boag AK, Keir I. Impact of appropriate empirical antimicrobial therapy on outcome of dogs with septic peritonitis. J Vet Emerg Crit Care. (2015) 25:152–9. doi: 10.1111/vec.12273

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Summers AM, Vezzi N, Gravelyn T, Culler C, Guillaumin J. Clinical features and outcome of septic shock in dogs: 37 Cases (2008-2015). J Vet Emerg Crit Care. (2020) doi: 10.1111/vec.13038

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Troia R, Mascalzoni G, Agnoli C, Lalonde-Paul D, Giunti M, Goggs R. Cytokine and chemokine profiling in cats with sepsis and septic shock. Front Vet Sci. (2020) 7:305. doi: 10.3389/fvets.2020.00305

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Hansen AE. Evaluation of a commercially available human serum amyloid A (SAA) turbidimetric immunoassay for determination of feline SAA concentration. Vet Res Commun. (2006) 30:863–72. doi: 10.1007/s11259-006-3373-6

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Troia R, Gruarin M, Foglia A, Agnoli C, Dondi F, Giunti M. Serum amyloid A in the diagnosis of feline sepsis. J Vet Diagn Invest. (2017) 29:856–9. doi: 10.1177/1040638717722815

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Hayes G, Mathews K, Doig G, Kruth S, Boston S, Nykamp S, et al. The feline acute patient physiologic and laboratory evaluation (feline APPLE) score: a severity of illness stratification system for hospitalized cats. J Vet Intern Med. (2011) 25:26–38. doi: 10.1111/j.1939-1676.2010.0648.x

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Klainbart S, Agi L, Bdolah-Abram T, Kelmer E, Aroch I. Clinical, laboratory and hemostatic findings in cats with naturally occurring sepsis. J Am Vet Med Assoc. (2017) 251:1025–34. doi: 10.2460/javma.251.9.1025

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Brady CA, Otto CM, Van Winkle TJ, King LG. Severe sepsis in cats: 29 cases (1986-1998). J Am Vet Med Assoc. (2000) 217:531–5. doi: 10.2460/javma.2000.217.531

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Shea EK, Dombrowski SC, Silverstein DC. Survival analysis of hypotensive cats admitted to an intensive care unit with or without hyperlactatemia: 39 cases (2005-2011). J Am Vet Med Assoc. (2017) 250:887–93. doi: 10.2460/javma.250.8.887

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Reineke EL, Rees C, Drobatz KJ. Association of blood lactate concentration with physical perfusion variables, blood pressure, and outcome for cats treated at an emergency service. J Am Vet Med Assoc. (2015) 247:79–84. doi: 10.2460/javma.247.1.79

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Redavid LA, Sharp CR, Mitchell MA, Beckel NF. Hyperlactatemia and serial lactate measurements in sick cats. J Vet Emerg Crit Care. (2016) 26:495–501. doi: 10.1111/vec.12496

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Cortellini S, Seth M, Kellet-Gregory LM. Plasma lactate concentrations in septic peritonitis: a retrospective study of 83 dogs (2007-2012). J Vet Emerg Crit Care. (2015) 25:388–95. doi: 10.1111/vec.12234

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Brunetto MA, Gomes MO, Andre MR, Teshima E, Gonçalves KN, Pereira GT, et al. Effects of nutritional support on hospital outcome in dogs and cats. J Vet Emerg Crit Care. (2010) 20:224–31. doi: 10.1111/j.1476-4431.2009.00507.x

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Girardot T, Rimmelè T, Venet F, Monneret G. Apoptosis-induced lymphopenia in sepsis and other severe injuries. Apoptosis. (2017) 22:295–305. doi: 10.1007/s10495-016-1325-3

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Spapen HD, Jacobs R, Honorè PM. Sepsis-induced multi-organ dysfunction syndrome: a mehanistic approach. J Emerg Crit Care Med. (2017) 1:27. doi: 10.21037/jeccm.2017.09.04

CrossRef Full Text | Google Scholar

28. Sachs EKJ, Julius TM, Claypool SA, Clare M. Comparison of cephalic and jugular plasma lactate concentrations in sick cats: a pilot study. J vet Emerg Crit Care. (2017) 27:193–7. doi: 10.1111/vec.12582

PubMed Abstract | CrossRef Full Text | Google Scholar